2021
Evaluation and Management of Alcohol use Disorder among Older Adults
Joshi P, Duong KT, Trevisan LA, Wilkins KM. Evaluation and Management of Alcohol use Disorder among Older Adults. Current Geriatrics Reports 2021, 10: 82-90. PMID: 34336549, PMCID: PMC8308079, DOI: 10.1007/s13670-021-00359-5.Peer-Reviewed Original ResearchAlcohol use disorderOlder adultsUse disordersTreatment of AUDPatient screening resultsScreening resultsStandardized screening toolsMost older adultsReviewThe prevalenceSUD treatmentPsychosocial treatmentsAlcohol misuseSubstance misuseBrief interventionScreening toolSubstance useMutual help groupsAdultsCOVID-19 pandemicTreatmentPhysical distancingDisordersLaboratory testsScreeningIncreased isolation
2019
THE STATE OF GERIATRIC PSYCHIATRY TRAINING IN GENERAL PSYCHIATRY RESIDENCY: DATA FROM A NATIONAL SURVEY OF U.S. PROGRAM DIRECTORS
Meyen R, Conroy M, Forester B, Hobbs K, Kirwin P, Schillerstrom J, Wilkins K. THE STATE OF GERIATRIC PSYCHIATRY TRAINING IN GENERAL PSYCHIATRY RESIDENCY: DATA FROM A NATIONAL SURVEY OF U.S. PROGRAM DIRECTORS. American Journal Of Geriatric Psychiatry 2019, 27: s163. DOI: 10.1016/j.jagp.2019.01.116.Peer-Reviewed Original ResearchMental healthPsychiatry residency programsAnonymous multiple-choice surveySubstance use disordersProgram directorsResidency programsGeriatric psychiatry trainingUnited States populationU.S. program directorsElderly patientsSubspecialty careMultiple-choice surveyNeurocognitive disordersAmerican Medical Association's FellowshipUse disordersElderly adultsGeriatric psychiatristsMedicine reportIOM reportGeriatric psychiatryGeriatric trainingOlder adultsSubspecialty trainingSubstance useGeriatric psychiatry fellowship
2017
Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions
Hassell C, Wilkins K, Trevisan L. Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions. Current Treatment Options In Psychiatry 2017, 4: 102-115. DOI: 10.1007/s40501-017-0107-z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSubstance use disordersEvidence-based treatmentsUse disordersGeriatric populationEvidence-based pharmacological treatment optionsAvailable evidence-based treatmentsHigh-quality clinical trialsOlder adultsAvailable pharmacological treatmentsPharmacological treatment optionsLimitations of treatmentPharmacological treatmentTreatment optionsClinical trialsCertain drugsYoung adultsAdverse effectsDisordersTreatmentAdultsHigh rateUnique needsPopulationBaby boomer generationDysfunction